TCL Archive NCI Splits Prevention and control Division; Rimer to Direct Division Of Cancer Conrol July 25, 1997
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014